Mequon-based Titan Spine LLC today announced it has hired Ted Bird to the new position of chief commercial officer.
Bird will lead Titan Spine’s global sales, marketing, strategic partnering and national target accounts.
Previously, Bird was president of Bird Medical, a strategic consulting firm for health care manufacturers, as well as non-executive chairman of the board for ApiFix, an Israel-based startup focused on minimally-invasive, fusionless technology to correct early onset and adolescent scoliosis. Bird also has led divisions at Orthofix, including president of the spine fixation business, Depuy Spine, and Medtronic Sofamor Danek. He holds a bachelor’s in international relations and political science from Brown University.
Titan Spine develops and markets titanium interbody spinal implants equipped with a special grooved surface that encourages bone growth. It was founded in 2006 and the company is currently working to commercialize its nanoLOCk surface interbody device.
“Ted is a well-respected medical device commercial leader with more than 30 years of sales, marketing and senior executive experience at leading health care companies,” said Peter Ullrich, chief executive officer of Titan Spine. “He is well-known and highly regarded in the spine industry, with extensive relationships among surgeons and distributors built from over 25 years working with spine companies including ApiFix, Orthofix, Depuy Spine and Medtronic Sofamor Danek. We look forward to Ted’s significant spine commercialization expertise and contributions as Titan Spine continues ramping up its full U.S. launch of our Endoskeleton titanium implants featuring our groundbreaking nanoLOCK surface technology, the only nano-cleared interbody device on the market shown to elicit a nano-cellular level response for bone growth.”
“I am incredibly excited and honored to be joining the Titan Spine team,” Bird said. “The company has been at the forefront of moving the interbody device marketplace away from PEEK and towards titanium surface-enhanced implants for improved patient outcomes with validated, peer-reviewed science and strong support from surgeons, hospitals and the U.S. government. I look forward to working closely with the talented team at Titan Spine to continue building on the positive momentum that the company continues to generate and help lead the next phase of the company’s evolution and growth.”
